Cell line development, at scale.

High-throughput cell line screening under real manufacturing conditions.

Cell line development, at scale.

High-throughput cell line screening under real manufacturing conditions.

Cell line development, at scale.

High-throughput cell line screening under real manufacturing conditions.

BACKED BY:

BACKED BY:

BACKED BY:

Our Technology

Unique DNA barcodes combined with multi-omic characterization.
An unprecedented understanding of each clone.

Barcode

Barcode

Barcode

Each cell line receives a unique, heritable DNA barcode. Every descendant carries the same identifier.

Culture

Culture

Culture

Thousands of barcoded clones grown together in one fed-batch run under manufacturing-relevant conditions.

Characterize

Characterize

Characterize

Productivity and quality measured for every clone simultaneously using FACS-based assays and sequencing.

Retrieve

Retrieve

Retrieve

Top clones isolated with >99.8% on-target precision. Output is a manufacturing-ready cell line with a full performance dataset.

Why Biolinco?

Better decisions at scale.

>2500x

More clones screened per run.

100-1,000x

Lower cost per clone.

>200,000

Unique barcodes per library.

Meet the team

Kent Rapp, PhD.

Co-Founder & CEO

Junneng (Kevin) Wen, PhD.

Co-Founder & CTO

Reza Kalhor, PhD.

Scientific Co-Founder

Michael Betenbaugh, PhD.

Scientific Co-Founder

Kent Rapp, PhD.

Co-Founder & CEO

Junneng (Kevin) Wen, PhD.

Co-Founder & CTO

Reza Kalhor, PhD.

Scientific Co-Founder

Michael Betenbaugh, PhD.

Scientific Co-Founder

Kent Rapp, PhD.

Co-Founder & CEO

Junneng (Kevin) Wen, PhD.

Co-Founder & CTO

Reza Kalhor, PhD.

Scientific Co-Founder

Michael Betenbaugh, PhD.

Scientific Co-Founder

Biolinco News

Techstars

Biolinco Presents at Techstars Spring 2026 Demo Day

Jun 1, 2026

Biolinco presents its high-throughput cell line development platform to investors and industry leaders at Techstars Spring 2026 Demo Day.

Techstars

Biolinco Presents at Techstars Spring 2026 Demo Day

Jun 1, 2026

Biolinco presents its high-throughput cell line development platform to investors and industry leaders at Techstars Spring 2026 Demo Day.

FastForward U

Judge's Prize at FastForward U Spark Showcase

Dec 1, 2023

Biolinco wins the Judge's Prize at Johns Hopkins FastForward U's Fall 2023 Spark Showcase, competing among 34 early-stage student startups.

FastForward U

Judge's Prize at FastForward U Spark Showcase

Dec 1, 2023

Biolinco wins the Judge's Prize at Johns Hopkins FastForward U's Fall 2023 Spark Showcase, competing among 34 early-stage student startups.

Johns Hopkins BME

Featured at JHU Innovation Summit

Jun 1, 2023

Biolinco presents at Johns Hopkins' inaugural Innovation Summit, organized by JHTV, Carey Business School, and Blackbird Laboratories.

Johns Hopkins BME

Featured at JHU Innovation Summit

Jun 1, 2023

Biolinco presents at Johns Hopkins' inaugural Innovation Summit, organized by JHTV, Carey Business School, and Blackbird Laboratories.

Cell line development, at scale.

High-throughput cell line screening under real manufacturing conditions.

Cell line development, at scale.

High-throughput cell line screening under real manufacturing conditions.

Cell line development, at scale.

High-throughput cell line screening under real manufacturing conditions.

BACKED BY:

BACKED BY:

BACKED BY:

Unique DNA barcodes combined with multi-omic characterization.An unprecedented understanding of each clone.

Barcode

Barcode

Barcode

Each cell line receives a unique, heritable DNA barcode. Every descendant carries the same identifier.

Culture

Culture

Culture

Thousands of barcoded clones grown together in one fed-batch run under manufacturing-relevant conditions.

Characterize

Characterize

Characterize

Productivity and quality measured for every clone simultaneously using FACS-based assays and sequencing.

Retrieve

Retrieve

Retrieve

Top clones isolated with >99.8% on-target precision. Output is a manufacturing-ready cell line with a full performance dataset.

Better decisions at scale.

>2500x

>2500x

More clones screened per run.

More clones screened per run.

100-1,000x

100-1,000x

Lower cost per clone.

Lower cost per clone.

>200,000

>200,000

Unique barcodes per library.

Unique barcodes per library.

Kent Rapp, PhD.

Junneng (Kevin) Wen, PhD.

Reza Kalhor, PhD.

Michael Betenbaugh, PhD.

Kent Rapp, PhD.

Junneng (Kevin) Wen, PhD.

Reza Kalhor, PhD.

Michael Betenbaugh, PhD.

Kent Rapp, PhD.

Junneng (Kevin) Wen, PhD.

Reza Kalhor, PhD.

Michael Betenbaugh, PhD.

Biolinco Presents at Techstars Spring 2026 Demo Day

Biolinco Presents at Techstars Spring 2026 Demo Day

Judge's Prize at FastForward U Spark Showcase

Judge's Prize at FastForward U Spark Showcase

Featured at JHU Innovation Summit

Featured at JHU Innovation Summit

Get in touch.

Tell us about your cell line development needs.

Visit

1812 Ashland Ave., G06, Baltimore, MD 21205

Email

info@biolinco.com

Get in touch.

Tell us about your cell line development needs.

Visit

1812 Ashland Ave., G06, Baltimore, MD 21205

Email

info@biolinco.com

Get in touch.

Tell us about your cell line development needs.

Visit

1812 Ashland Ave., G06, Baltimore, MD 21205

Email

info@biolinco.com

1812 Ashland Avenue, Garden Level - G06 Baltimore, MD 21205

Copyright © 2026 Biolinco Inc. All rights reserved.

1812 Ashland Avenue, Garden Level - G06 Baltimore, MD 21205

Copyright © 2026 Biolinco Inc. All rights reserved.

1812 Ashland Avenue, Garden Level - G06 Baltimore, MD 21205

Unique DNA barcodes combined with multi-omic characterization.
An unprecedented understanding of each clone.

1812 Ashland Ave., G0
6, Baltimore, MD 21205

1812 Ashland Ave., G0
6, Baltimore, MD 21205

1812 Ashland Ave., G0
6, Baltimore, MD 21205

1812 Ashland Avenue, Garden Level - G06
Baltimore, MD 21205

1812 Ashland Avenue, Garden Level - G06
Baltimore, MD 21205

1812 Ashland Avenue, Garden Level - G06
Baltimore, MD 21205

Unique DNA barcodes combined with multi-omic characterization.
An unprecedented understanding of each clone.